Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

22.4%

112 terminated/withdrawn out of 500 trials

Success Rate

70.6%

-15.9% vs industry average

Late-Stage Pipeline

21%

104 trials in Phase 3/4

Results Transparency

64%

173 of 269 completed trials have results

Key Signals

71 recruiting173 with results65 terminated47 withdrawn

Enrollment Performance

Analytics

N/A
206(49.4%)
Phase 4
79(18.9%)
Phase 2
65(15.6%)
Phase 1
34(8.2%)
Phase 3
25(6.0%)
Early Phase 1
8(1.9%)
417Total
N/A(206)
Phase 4(79)
Phase 2(65)
Phase 1(34)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (500)

Showing 20 of 500 trials
NCT05929911Not ApplicableRecruiting

Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD

Role: lead

NCT06582719Not ApplicableSuspended

Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)

Role: lead

NCT04611529Phase 4Completed

Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.

Role: lead

NCT05460611Not ApplicableRecruiting

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Role: lead

NCT07124598Not ApplicableRecruiting

Virtual Intelligence for Transformative Lifestyle Solutions in Pain

Role: lead

NCT07634393Phase 4Not Yet Recruiting

Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment

Role: lead

NCT07148206Phase 3Not Yet Recruiting

Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial

Role: lead

NCT07634679Not ApplicableNot Yet Recruiting

Impact of a Bladder Flap on Cesarean Scar Niche Development

Role: lead

NCT07635719Not ApplicableNot Yet Recruiting

Coblator Wand Comparative Analysis

Role: lead

NCT07146230Phase 2Not Yet Recruiting

The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2

Role: lead

NCT07631598Not ApplicableNot Yet Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

Role: lead

NCT07625267Phase 4Not Yet Recruiting

Non-antibiotic Management in Acute Uncomplicated Diverticulitis

Role: lead

NCT07625917Not ApplicableRecruiting

Feasibility of Internet-based HIV Prevention Research

Role: lead

NCT04139304Early Phase 1Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Role: collaborator

NCT03697577Active Not Recruiting

CDK and Body Composition Study

Role: lead

NCT07109817Phase 2Recruiting

Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer

Role: lead

NCT05972681Phase 4Terminated

The PAIN (Pelvic Area Injection for Numbness) Study

Role: lead

NCT07595302Phase 4Not Yet Recruiting

Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain

Role: lead

NCT00911118Phase 1Completed

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

Role: collaborator

NCT06382012Phase 2Recruiting

Antiemetic Fosaprepitant To Remedy Nausea and Vomiting

Role: lead